Related Experiment Videos
[Bacteriological and clinical studies on cefozopran in pediatric field]
T Nishimura1, K Tabuki, M Takagi
1Department of Pediatrics, Osaka Medical College.
Insights
Cefozopran (CZOP) effectively treated pediatric bacterial infections, showing excellent or good results in most cases. Bacterial eradication was achieved, with minimal side effects observed in a small number of patients.
Area of Science:
- Pediatric infectious diseases
- Bacteriology
- Clinical pharmacology
Background:
- Cefozopran (CZOP) is a novel cephalosporin antibiotic.
- Clinical efficacy and safety data for CZOP in pediatric populations are limited.
- Bacterial infections in children require effective and safe therapeutic options.
Observation:
- Clinical studies were conducted on 17 pediatric patients with bacterial infections.
- Infections included purulent tonsillitis, acute pneumonia, urinary tract infections, and enteritis.
- Bacterial isolates and clinical outcomes were monitored during treatment.
Findings:
- Cefozopran demonstrated high efficacy, with excellent or good outcomes in 14 out of 17 patients.
- Complete eradication of 9 isolated bacterial strains was achieved.
- Adverse events were infrequent, including rash in one patient and transient laboratory abnormalities.
Implications:
- Cefozopran shows promise as a safe and effective treatment for various pediatric bacterial infections.
- Further research may support the broader clinical use of Cefozopran in pediatric infectious disease management.
- The findings contribute to the understanding of Cefozopran's therapeutic profile in children.
Abstract:
We carried out clinical studies on cefozopran (CZOP, SCE-2787). The results are summarized as follows. Treatment with CZOP was made in 17 cases of pediatric bacterial infections including 2 cases of purulent tonsillitis, 11 cases of acute pneumonia and 2 cases each of urinary tract infections and enteritis. Results obtained were excellent in 12 cases, good in 2 cases, fair in 2 cases and poor in 1 case. All of 9 isolated bacteria were eradicated by the treatment. As side effects and laboratory test results, rash was observed in one case and transient increase of platelets in one case, slight increase of eosinophil in 2 cases and transient elevation of GPT and GOT.GPT in one case.